Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from New, simplified versus standard photodynamic therapy (PDT) regimen for superficial and nodular basal cell carcinoma (BCC): A single-blind, non-inferiority, randomised controlled multicentre study. Local targets link to admitted publications; unresolved targets remain external evidence.
A systematic review of worldwide incidence of nonmelanoma skin cancer
10.1111/j.1365-2133.2012.10830.x · 2012 · External reference
British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021
10.1111/bjd.20524 · 2021 · External reference
Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma
10.1111/bjd.13066 · 2014 · External reference
Metastatic basal cell carcinoma: report of two cases and literature review
10.1177/120347540500900104 · 2005 · External reference
European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications—actinic keratoses, Bowen’s disease and basal cell carcinomas.
10.1111/jdv.16017 · 2019 · External reference
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges
10.1002/(sici)1097-0142(19970615)79:12<2282::aid-cncr2>3.0.co;2-o · 1997 · External reference
Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up.
10.1111/j.1468-3083.2008.02946.x · 2009 · External reference
Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours
10.1016/1011-1344(95)90253-8 · 1995 · External reference
Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy
10.1046/j.1365-2133.2000.04000.x · 2000 · External reference
Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up
10.2340/00015555-0129 · 2006 · External reference
Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer
10.1016/j.pdpdt.2009.09.001 · 2009 · External reference
Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
10.2340/00015555-1448 · 2012 · External reference
Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up
10.1016/j.jaad.2013.02.014 · 2013 · External reference
Eliminating waste in US health care
10.1001/jama.2012.362 · 2012 · External reference
Is a single day patient friendly methyl aminolevulinate photodynamic therapy illumination scheme for superficial basal cell carcinoma feasible? A randomized multicenter pilot trial.
10.1080/09546634.2018.1484558 · 2019 · External reference
Basal cell carcinoma: biology, morphology and clinical implications.
10.1038/modpathol.3800512 · 2006 · External reference
Non-Melanoma Skin Cancers: Biological and Clinical Features.
10.3390/ijms21155394 · 2020 · External reference
Why classify basal cell carcinomas?
10.1046/j.1365-2559.1998.00431.x · 1998 · External reference
Guidelines for practical use of MAL-PDT in non-melanoma skin cancer
10.1111/j.1468-3083.2009.03430.x · 2010 · External reference
Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial
2008 · External reference
Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
10.1016/s1470-2045(13)70530-8 · 2014 · External reference
Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions
10.1111/j.1365-2133.2012.11083.x · 2012 · External reference
Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up.
10.1111/j.1524-4725.1989.tb03166.x · 1989 · External reference
Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities.
10.3390/molecules25225398 · 2020 · External reference
Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial
10.1016/j.jid.2016.03.043 · 2016 · External reference
Photodynamic therapy with topical methyl aminolaevulinate for ’difficult-to-treat’ basal cell carcinoma.
10.1111/j.1365-2133.2005.06484.x · 2005 · External reference
Accuracy of biopsy sampling for subtyping basal cell carcinoma
10.1016/j.jaad.2011.02.042 · 2012 · External reference
A new photodynamic therapy protocol for nodular basal cell carcinoma treatment: Effectiveness and long-term follow-up
10.1016/j.pdpdt.2021.102668 · 2022 · External reference
Single visit PDT for basal cell carcinoma—A new therapeutic protocol
10.1016/j.pdpdt.2019.04.016 · 2019 · External reference
Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma.
10.1159/000524745 · 2022 · External reference
